Damien Mcdevitt serves as Executive at AKCEA THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Damien Mcdevitt has executed 10 insider transactions totaling $268.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 12, 2020 involved transacting 242,978 shares valued at $4.4M.
Damien Mcdevitt currently holds 242,978 shares of AKCEA THERAPEUTICS, INC. (AKCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Damien Mcdevitt has been a net seller of AKCA stock. They have purchased $0 and sold $268.5K worth of shares.
Damien Mcdevitt's most recent insider trade was on Oct 12, 2020, when they sold 242,978 shares at $18.15 per share.
Get notified when new Form 4 filings are submitted
| $18.12 |
| Discretionary |
| Aug 31, 2020 | AKCA | $15.9K | Award | 1,104 | $14.40 | Discretionary |
| Mar 23, 2020 | AKCA | $110.6K | Sale | 9,417 | $11.75 | Discretionary |
| Mar 19, 2020 | AKCA | $0 | Award | 55,200 | $N/A | Discretionary |
| Mar 19, 2020 | AKCA | $0 | Award | 60,000 | $N/A | Discretionary |
| Sep 19, 2019 | AKCA | $0 | Award | 200,000 | $N/A | Discretionary |
| Jul 15, 2019 | IONS | $0 | Option Exercise | 3,542 | $N/A | Discretionary |
| Jul 15, 2019 | IONS | $83.1K | Payment | 1,225 | $67.86 | Discretionary |
| Jul 1, 2019 | IONS | $11.7K | Other | 256 | $45.70 | Discretionary |